Selected research
Industry Research
PRF Treatment Industry Research Report 2026
Market perspective
The global PRF Treatment market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the PRF Treatment market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the PRF Treatment market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the PRF Treatment market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of PRF Treatment include HB Health, Grifols International S.A., Kedrion S.p.A., LFB, Bio Products Laboratory Ltd, China Biologic Products, Inc., Octapharma, BioLife Plasma Services and Cambryn Biologics LLC, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global PRF Treatment market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to PRF Treatment.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
PRF Treatment Market by Company
HB Health
Grifols International S.A.
Kedrion S.p.A.
LFB
Bio Products Laboratory Ltd
China Biologic Products, Inc.
Octapharma
BioLife Plasma Services
Cambryn Biologics LLC
Biotest
CSL Ltd.
Santa Maria
PRF Treatment Segment by Type
Autologous
Allogenic
PRF Treatment Segment by Application
Plastic Surgery
Orthopedics
Dermatology
Androgenic Alopecia
Dental
Cardiac Muscle Injury
Nerve Injury
Others
PRF Treatment Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global PRF Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of PRF Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of PRF Treatment.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of PRF Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Autologous
- Allogenic
Applications
- Plastic Surgery
- Orthopedics
- Dermatology
- Androgenic Alopecia
- Dental
- Cardiac Muscle Injury
- Nerve Injury
- Others
Companies covered
- HB Health
- Grifols International S.A.
- Kedrion S.p.A.
- LFB
- Bio Products Laboratory Ltd
- China Biologic Products, Inc.
- Octapharma
- BioLife Plasma Services
- Cambryn Biologics LLC
- Biotest
- CSL Ltd.
- Santa Maria
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 PRF Treatment by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Autologous
- 2.2.3 Allogenic
- 2.3 PRF Treatment by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Plastic Surgery
- 2.3.3 Orthopedics
- 2.3.4 Dermatology
- 2.3.5 Androgenic Alopecia
- 2.3.6 Dental
- 2.3.7 Cardiac Muscle Injury
- 2.3.8 Nerve Injury
- 2.3.9 Others
- 2.4 Assumptions and Limitations
3 PRF Treatment Breakdown Data by Type
- 3.1 Global PRF Treatment Historic Market Size by Type (2021-2026)
- 3.2 Global PRF Treatment Forecasted Market Size by Type (2027-2032)
4 PRF Treatment Breakdown Data by Application
- 4.1 Global PRF Treatment Historic Market Size by Application (2021-2026)
- 4.2 Global PRF Treatment Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global PRF Treatment Market Perspective (2021-2032)
- 5.2 Global PRF Treatment Growth Trends by Region
- 5.2.1 Global PRF Treatment Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 PRF Treatment Historic Market Size by Region (2021-2026)
- 5.2.3 PRF Treatment Forecasted Market Size by Region (2027-2032)
- 5.3 PRF Treatment Market Dynamics
- 5.3.1 PRF Treatment Industry Trends
- 5.3.2 PRF Treatment Market Drivers
- 5.3.3 PRF Treatment Market Challenges
- 5.3.4 PRF Treatment Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top PRF Treatment Players by Revenue
- 6.1.1 Global Top PRF Treatment Players by Revenue (2021-2026)
- 6.1.2 Global PRF Treatment Revenue Market Share by Players (2021-2026)
- 6.2 Global PRF Treatment Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of PRF Treatment Head Office and Area Served
- 6.4 Global PRF Treatment Players, Product Type & Application
- 6.5 Global PRF Treatment Manufacturers Established Date
- 6.6 Global PRF Treatment Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America PRF Treatment Market Size (2021-2032)
- 7.2 North America PRF Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America PRF Treatment Market Size by Country (2021-2026)
- 7.4 North America PRF Treatment Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe PRF Treatment Market Size (2021-2032)
- 8.2 Europe PRF Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe PRF Treatment Market Size by Country (2021-2026)
- 8.4 Europe PRF Treatment Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific PRF Treatment Market Size (2021-2032)
- 9.2 Asia-Pacific PRF Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific PRF Treatment Market Size by Country (2021-2026)
- 9.4 Asia-Pacific PRF Treatment Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America PRF Treatment Market Size (2021-2032)
- 10.2 South America PRF Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America PRF Treatment Market Size by Country (2021-2026)
- 10.4 South America PRF Treatment Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa PRF Treatment Market Size (2021-2032)
- 11.2 Middle East & Africa PRF Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa PRF Treatment Market Size by Country (2021-2026)
- 11.4 Middle East & Africa PRF Treatment Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 HB Health
- 12.1.1 HB Health Company Information
- 12.1.2 HB Health Business Overview
- 12.1.3 HB Health Revenue in PRF Treatment Business (2021-2026)
- 12.1.4 HB Health PRF Treatment Product Portfolio
- 12.1.5 HB Health Recent Developments
- 12.2 Grifols International S.A.
- 12.2.1 Grifols International S.A. Company Information
- 12.2.2 Grifols International S.A. Business Overview
- 12.2.3 Grifols International S.A. Revenue in PRF Treatment Business (2021-2026)
- 12.2.4 Grifols International S.A. PRF Treatment Product Portfolio
- 12.2.5 Grifols International S.A. Recent Developments
- 12.3 Kedrion S.p.A.
- 12.3.1 Kedrion S.p.A. Company Information
- 12.3.2 Kedrion S.p.A. Business Overview
- 12.3.3 Kedrion S.p.A. Revenue in PRF Treatment Business (2021-2026)
- 12.3.4 Kedrion S.p.A. PRF Treatment Product Portfolio
- 12.3.5 Kedrion S.p.A. Recent Developments
- 12.4 LFB
- 12.4.1 LFB Company Information
- 12.4.2 LFB Business Overview
- 12.4.3 LFB Revenue in PRF Treatment Business (2021-2026)
- 12.4.4 LFB PRF Treatment Product Portfolio
- 12.4.5 LFB Recent Developments
- 12.5 Bio Products Laboratory Ltd
- 12.5.1 Bio Products Laboratory Ltd Company Information
- 12.5.2 Bio Products Laboratory Ltd Business Overview
- 12.5.3 Bio Products Laboratory Ltd Revenue in PRF Treatment Business (2021-2026)
- 12.5.4 Bio Products Laboratory Ltd PRF Treatment Product Portfolio
- 12.5.5 Bio Products Laboratory Ltd Recent Developments
- 12.6 China Biologic Products, Inc.
- 12.6.1 China Biologic Products, Inc. Company Information
- 12.6.2 China Biologic Products, Inc. Business Overview
- 12.6.3 China Biologic Products, Inc. Revenue in PRF Treatment Business (2021-2026)
- 12.6.4 China Biologic Products, Inc. PRF Treatment Product Portfolio
- 12.6.5 China Biologic Products, Inc. Recent Developments
- 12.7 Octapharma
- 12.7.1 Octapharma Company Information
- 12.7.2 Octapharma Business Overview
- 12.7.3 Octapharma Revenue in PRF Treatment Business (2021-2026)
- 12.7.4 Octapharma PRF Treatment Product Portfolio
- 12.7.5 Octapharma Recent Developments
- 12.8 BioLife Plasma Services
- 12.8.1 BioLife Plasma Services Company Information
- 12.8.2 BioLife Plasma Services Business Overview
- 12.8.3 BioLife Plasma Services Revenue in PRF Treatment Business (2021-2026)
- 12.8.4 BioLife Plasma Services PRF Treatment Product Portfolio
- 12.8.5 BioLife Plasma Services Recent Developments
- 12.9 Cambryn Biologics LLC
- 12.9.1 Cambryn Biologics LLC Company Information
- 12.9.2 Cambryn Biologics LLC Business Overview
- 12.9.3 Cambryn Biologics LLC Revenue in PRF Treatment Business (2021-2026)
- 12.9.4 Cambryn Biologics LLC PRF Treatment Product Portfolio
- 12.9.5 Cambryn Biologics LLC Recent Developments
- 12.10 Biotest
- 12.10.1 Biotest Company Information
- 12.10.2 Biotest Business Overview
- 12.10.3 Biotest Revenue in PRF Treatment Business (2021-2026)
- 12.10.4 Biotest PRF Treatment Product Portfolio
- 12.10.5 Biotest Recent Developments
- 12.11 CSL Ltd.
- 12.11.1 CSL Ltd. Company Information
- 12.11.2 CSL Ltd. Business Overview
- 12.11.3 CSL Ltd. Revenue in PRF Treatment Business (2021-2026)
- 12.11.4 CSL Ltd. PRF Treatment Product Portfolio
- 12.11.5 CSL Ltd. Recent Developments
- 12.12 Santa Maria
- 12.12.1 Santa Maria Company Information
- 12.12.2 Santa Maria Business Overview
- 12.12.3 Santa Maria Revenue in PRF Treatment Business (2021-2026)
- 12.12.4 Santa Maria PRF Treatment Product Portfolio
- 12.12.5 Santa Maria Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst